FDA Panel OKs Use Of Anemia Drugs, Despite Study
A U.S. Food and Drug Administration panel said Monday that it was safe for kidney patients who do not require dialysis to continue use of erythropoiesis-stimulating agents made by Johnson &...To view the full article, register now.
Already a subscriber? Click here to view full article